Log in | Register

Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome

Mark W. Hall| Nina L. Knatz| Carol Vetterly| Steven Tomarello| Mark D. Wewers| Hans Dieter Volk| Joseph A. Carcillo
Pediatric Original
Volume 37, Issue 3 / March , 2011

Pages 525 - 532

Abstract

Purpose

Immunoparalysis defined by prolonged monocyte human leukocyte antigen DR depression is associated with adverse outcomes in adult severe sepsis and can be reversed with granulocyte macrophage colony-stimulating factor (GM-CSF). We hypothesized that immunoparalysis defined by whole-blood ex vivo lipopolysaccharide-induced tumor necrosis factor-alpha (TNFα) response <200 pg/mL beyond day 3 of multiple organ dysfunction syndrome (MODS) is similarly associated with nosocomial infection in children and can be reversed with GM-CSF.

Methods

In study period 1, we performed a multicenter cohort trial of transplant and nontransplant multiple organ dysfunction syndrome (MODS) patients (≥2 organ failure). In study period 2, we performed an open-label randomized trial of GM-CSF therapy for nonneutropenic, nontransplant, severe MODS patients (≥3 organ failure) with TNFα response <160 pg/mL.

Results

Immunoparalysis was observed in 34% of MODS patients (n = 70) and was associated with increased nosocomial infection (relative risk [RR] 3.3, 95% confidence interval [1.8–6.0] p < 0.05) and mortality (RR 5.8 [2.1–16] p < 0.05). TNFα response <200 pg/mL throughout 7 days after positive culture was associated with persistent nosocomial infection, whereas recovery above 200 pg/mL was associated with resolution of infection (p < 0.05). In study period 2, GM-CSF therapy facilitated rapid recovery of TNFα response to >200 pg/mL by 7 days (p < 0.05) and prevented nosocomial infection (no infections in seven patients versus eight infections in seven patients) (p < 0.05).

Conclusions

Similar to in adults, immunoparalysis is a potentially reversible risk factor for development of nosocomial infection in pediatric MODS. Whole-blood ex vivo TNFα response is a promising biomarker for monitoring this condition.

Keywords

References

  1. Leclerc F, Leteurtre S, Duhamel A, Grandbastien B, Proulx F, Martinot A, Gauvin F, Hubert P, Lacroix J (2005) Cumulative influence of organ dysfunctions and septic state on mortality of critically ill children. Am J Resp Crit Care Med 171:348–353
    • View reference on publisher's website
    • View reference on PubMed
  2. Pizzo PA, Rubin M, Freifeld A, Walsh TJ (1991) The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies. J Pediatr 119:679–694
    • View reference on publisher's website
    • View reference on PubMed
  3. Felmet KA, Hall MW, Clark RS, Jaffe R, Carcillo JA (2005) Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol 174:3765–3772
    • View reference on PubMed
  4. Hoffman JA, Weinberg KI, Azen CG, Horn MV, Dukes L, Starnes VA, Woo MS (2004) Human leukocyte antigen-DR expression on peripheral blood monocytes and the risk of pneumonia in pediatric lung transplant recipients. Transpl Infect Dis 6:147–155
    • View reference on publisher's website
    • View reference on PubMed
  5. Volk HD, Reinke P, Krausch D, Zuckermann H, Asadullah K, Muller JM, Docke WD, Kox WJ (1996) Monocyte deactivation–rationale for a new therapeutic strategy in sepsis. Intensive Care Med 22(Suppl 4):S474–S481
  6. Monneret G, Finck ME, Venet F, Debard AL, Bohe J, Bienvenu J, Lepape A (2004) The anti-inflammatory response dominates after septic shock: Association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 95:193–198
    • View reference on publisher's website
    • View reference on PubMed
  7. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC Jr (1990) Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 77:204–207
    • View reference on publisher's website
    • View reference on PubMed
  8. Reinke P, Volk HD (1992) Diagnostic and predictive value of an immune monitoring program for complications after kidney transplantation. Urol Int 49:69–75
    • View reference on publisher's website
    • View reference on PubMed
  9. Ho YP, Sheen IS, Chiu CT, Wu CS, Lin CY (2006) A strong association between down-regulation of HLA-DR expression and the late mortality in patients with severe acute pancreatitis. Am J Gastroenterol 101:1117–1124
    • View reference on publisher's website
    • View reference on PubMed
  10. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W (1997) Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment. Nat Med 3:678–681
    • View reference on publisher's website
    • View reference on PubMed
  11. Ploder M, Pelinka L, Schmuckenschlager C, Wessner B, Ankersmit HJ, Fuerst W, Redl H, Roth E, Spittler A (2006) Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients. Shock 25:129–134
    • View reference on PubMed
  12. Allen ML, Hoschtitzky JA, Peters MJ, Elliott M, Goldman A, James I, Klein NJ (2006) Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Crit Care Med 34:2658–2665
    • View reference on publisher's website
    • View reference on PubMed
  13. Woiciechowsky C, Asadullah K, Nestler D, Schoning B, Glockner F, Docke WD, Volk HD (1998) Diminished monocytic HLA-DR expression and ex vivo cytokine secretion capacity in patients with glioblastoma: Effect of tumor extirpation. J Neuroimmunol 84:164–171
    • View reference on publisher's website
    • View reference on PubMed
  14. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, Weber-Carstens S, Hasper D, Keh D, Zuckermann H, Reinke P, Volk HD (2009) GM-CSF to reverse sepsis-associated immunosuppression: A double-blind randomized placebo-controlled multicenter trial. Am J Respir Crit Care Med 180:640–648
    • View reference on publisher's website
    • View reference on PubMed
  15. Kox WJ, Bone RC, Krausch D, Docke WD, Kox SN, Wauer H, Egerer K, Querner S, Asadullah K, von Baehr R, Volk HD (1997) Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: Proof of principle. Arch Intern Med 157(4):389–393
    • View reference on publisher's website
    • View reference on PubMed
  16. Nakos G, Malamou-Mitsi VD, Lachana A, Karassavoglou A, Kitsiouli E, Agnandi N, Lekka ME (2002) Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma. Crit Care Med 30:1488–1494
    • View reference on publisher's website
    • View reference on PubMed
  17. Nierhaus A, Montag B, Timmler N, Frings DP, Gutensohn K, Jung R, Schneider CG, Pothmann W, Brassel AK, Schulte Am Esch J (2003) Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med 29:646–651
    • View reference on PubMed
  18. Rosenbloom AJ, Linden PK, Dorrance A, Penkosky N, Cohen-Melamed MH, Pinsky MR (2005) Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients. Chest 127:2139–2150
    • View reference on publisher's website
    • View reference on PubMed
  19. Doughty LA, Kaplan SS, Carcillo JA (1996) Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Crit Care Med 24:1137–1143
    • View reference on publisher's website
    • View reference on PubMed
  20. Pollack MM, Patel KM, Ruttimann UE (1996) Prism iii: An updated pediatric risk of mortality score. Crit Care Med 24:743–752
    • View reference on publisher's website
    • View reference on PubMed
  21. Bone RC (1996) Sir Isaac Newton, sepsis, sirs, and cars. Crit Care Med 24:1125–1128
    • View reference on publisher's website
    • View reference on PubMed
  22. Volk HD, Reinke P, Docke WD (2000) Clinical aspects: From systemic inflammation to ‘immunoparalysis’. Chem Immunol 74:162–177
    • View reference on publisher's website
    • View reference on PubMed
  23. Monneret G, Lepape A, Voirin N, Bohe J, Venet F, Debard AL, Thizy H, Bienvenu J, Gueyffier F, Vanhems P (2006) Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 32:1175–1183
  24. Volk HD, Reinke P, Docke WD (1999) Immunological monitoring of the inflammatory process: Which variables? When to assess? Eur J Surg Suppl 584:70–72
    • View reference on publisher's website
    • View reference on PubMed
  25. Flach R, Majetschak M, Heukamp T, Jennissen V, Flohe S, Borgermann J, Obertacke U, Schade FU (1999) Relation of ex vivo stimulated blood cytokine synthesis to post-traumatic sepsis. Cytokine 11:173–178
    • View reference on publisher's website
    • View reference on PubMed
  26. Spagnoli GC, Juretic A, Rosso R, Van Bree J, Harder F, Heberer M (1995) Expression of HLA-DR in granulocytes of polytraumatized patients treated with recombinant human granulocyte macrophage-colony-stimulating factor. Hum Immunol 43:45–50
    • View reference on publisher's website
    • View reference on PubMed
  27. Lendemans S, Kreuzfelder E, Waydhas C, Schade FU, Flohe S (2007) Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFN gamma) after severe trauma. Inflamm Res 56:38–44
    • View reference on publisher's website
    • View reference on PubMed
  28. Bundschuh DS, Barsig J, Hartung T, Randow F, Docke WD, Volk HD, Wendel A (1997) Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice. J Immunol 158:2862–2871
    • View reference on PubMed
  29. Flohe S, Lendemans S, Selbach C, Waydhas C, Ackermann M, Schade FU, Kreuzfelder E (2003) Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma. Crit Care Med 31:2462–2469
    • View reference on publisher's website
    • View reference on PubMed
  30. Fumeaux T, Pugin J (2002) Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Resp Crit Care Med 166:1475–1482
    • View reference on publisher's website
    • View reference on PubMed
  31. Presneill JJ, Harris T, Stewart AG, Cade JF, Wilson JW (2002) A randomized phase ii trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction. Am J Resp Crit Care Med 166:138–143
    • View reference on publisher's website
    • View reference on PubMed
  32. Herrmann F, Schulz G, Lindemann A, Meyenburg W, Oster W, Krumwieh D, Mertelsmann R (1988) Yeast-expressed granulocyte-macrophage colony-stimulating factor in cancer patients: A phase 1b clinical study. Behring Inst Mitt 83:107–118
    • View reference on PubMed
  33. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC (2007) Understanding the inflammatory cytokine response in pneumonia and sepsis: Results of the genetic and inflammatory markers of sepsis (genims) study. Arch Intern Med 167:1655–1663
    • View reference on publisher's website
    • View reference on PubMed
  34. Bultinck J, Brouckaert P, Cauwels A (2006) The in vivo contribution of hematopoietic cells to systemic TNF and IL-6 production during endotoxemia. Cytokine 36:160–166
    • View reference on publisher's website
    • View reference on PubMed
  35. Yan SF, Tritto I, Pinsky D, Liao H, Huang J, Fuller G, Brett J, May L, Stern D (1995) Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem 270:11463–11471
    • View reference on publisher's website
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement